AE Wealth Management LLC raised its stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 63.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,973 shares of the financial services provider’s stock after purchasing an additional 763 shares during the quarter. AE Wealth Management LLC’s holdings in iShares NASDAQ Biotechnology Index were worth $211,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Tarbox Family Office Inc. raised its stake in shares of iShares NASDAQ Biotechnology Index by 200.0% in the fourth quarter. Tarbox Family Office Inc. now owns 1,059 shares of the financial services provider’s stock worth $113,000 after purchasing an additional 706 shares during the last quarter. Bollard Group LLC raised its stake in shares of iShares NASDAQ Biotechnology Index by 200.0% in the fourth quarter. Bollard Group LLC now owns 1,176 shares of the financial services provider’s stock worth $126,000 after purchasing an additional 784 shares during the last quarter. Aua Capital Management LLC raised its stake in shares of iShares NASDAQ Biotechnology Index by 200.0% in the fourth quarter. Aua Capital Management LLC now owns 1,200 shares of the financial services provider’s stock worth $128,000 after purchasing an additional 800 shares during the last quarter. FNY Partners Fund LP purchased a new stake in shares of iShares NASDAQ Biotechnology Index in the third quarter worth approximately $133,000. Finally, Edge Wealth Management LLC raised its stake in shares of iShares NASDAQ Biotechnology Index by 381.8% in the fourth quarter. Edge Wealth Management LLC now owns 1,272 shares of the financial services provider’s stock worth $136,000 after purchasing an additional 1,008 shares during the last quarter. 27.28% of the stock is owned by hedge funds and other institutional investors.

Shares of iShares NASDAQ Biotechnology Index (IBB) opened at $107.35 on Tuesday. The company has a market capitalization of $9,470.00, a P/E ratio of 3.55 and a beta of 1.37. iShares NASDAQ Biotechnology Index has a 52-week low of $94.20 and a 52-week high of $119.30.

WARNING: This piece of content was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://theolympiareport.com/2018/02/13/ae-wealth-management-llc-has-211000-stake-in-ishares-nasdaq-biotechnology-index-ibb.html.

iShares NASDAQ Biotechnology Index Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.